BioHarvest Science – Vinia
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1
  • The company is scaling up its US marketing in line with a 2022 growth plan that aims for significant growth in sales orders following commercial entry in 2021
  • The initial phase will include TV and online advertising with a special focus on Christian programming, which includes TBN
  • BioHarvest Sciences is a Biotech firm which is the developer and owner of the proprietary and patent-protected bio-farming technology
  • BioHarvest Sciences Inc. (BHSC) is up 3.13 per cent, trading at C$0.33 per share at 12:58 pm ET

BioHarvest Sciences (BHSC) has announced the first multimedia campaign for VINIA in the USA, Phase 1.

The company is scaling up its US marketing in line with a 2022 growth plan. It aims for significant growth in sales orders following commercial entry in 2021.

The initial phase will include TV and online advertising focusing on Christian programming, which includes TBN. TBN (Trinity Broadcasting Network) is the world’s largest religious-based television network. As part of the sponsorship agreement with TBN, Sobel will appear on the network’s flagship shows hosted by Eric Metaxas and Mike Huckabee.

Ilan Sobel, the CEO of BioHarvest, commented on the news.

“We are delighted to launch our first integrated marketing campaign aimed at expanding our loyal customer base here in the USA. Bringing our new 20 Ton production facility online was integral to scaling global VINIA supply. This marketing launch is testament to the entire VINIA team’s coordinated dedication to making it happen.”

The company created the new 60-second VINIA commercial for the TBN campaign, starting Aug 15, 2022. The campaign underscores VINIA’s concept of “Cellular Nutrition” and the benefits of increased blood flow, bringing in Sobel and members of his own family.

BioHarvest Sciences is a Biotech firm which is the developer and owner of proprietary and patent-protected bio-farming technology. The technology can grow the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.

BioHarvest Sciences Inc. (BHSC) is up 3.13 per cent, trading at C$0.33 per share at 12:58 pm ET.


More From The Market Herald
Theratechnologies -CMO, Dr. Christian Marsolais

" Theratechnologies (TSX:TH) receives FDA approval

Theratechnologies (TH) has received U.S. Food and Drug Administration (FDA) approval for its Trogarzo to be administered by IV therapy.

" ScreenPro’s (CSE:SCRN) Naturevan expands distribution to Asia

ScreenPro’s (SCRN) wholly-owned subsidiary, Naturevan Nutrition, will expand the distribution of its products to Japan and South Korea.
MedMira Inc. - CEO, Hermes Chan

" MedMira (TSXV:MIR) provides progress update

MedMira (MIR) has appointed Dr. Sam Ratnam as its Director of Scientific and Regulatory Affairs and updated its regulatory progress in the U.S.
The Market Herald Video

" Psyence Group (CSE:PSYG) exports psilocybin mushrooms to Canada and Portugal

Psyence Group (PSYG) has successfully exported medical-grade psilocybin mushrooms to both Canada and Portugal.